| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.
|
Clin Infect Dis
|
2012
|
2.92
|
|
2
|
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
|
Int J Antimicrob Agents
|
2010
|
1.13
|
|
3
|
Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.
|
Int J Antimicrob Agents
|
2009
|
0.94
|
|
4
|
An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
|
J Infect Chemother
|
2010
|
0.89
|
|
5
|
Renal function as a predictor of linezolid-induced thrombocytopenia.
|
Int J Antimicrob Agents
|
2008
|
0.87
|
|
6
|
Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.
|
Biol Pharm Bull
|
2015
|
0.87
|
|
7
|
The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma.
|
Biol Pharm Bull
|
2006
|
0.84
|
|
8
|
Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics.
|
J Infect Chemother
|
2012
|
0.83
|
|
9
|
Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
|
J Infect Chemother
|
2010
|
0.82
|
|
10
|
Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
|
Dig Dis Sci
|
2006
|
0.82
|
|
11
|
Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detection.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2008
|
0.82
|
|
12
|
Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.
|
Int J Antimicrob Agents
|
2011
|
0.81
|
|
13
|
Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves.
|
J Infect Chemother
|
2011
|
0.80
|
|
14
|
High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2007
|
0.80
|
|
15
|
Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection.
|
J Pharm Biomed Anal
|
2007
|
0.80
|
|
16
|
HPLC method for measuring meropenem and biapenem concentrations in human peritoneal fluid and bile: application to comparative pharmacokinetic investigations.
|
J Chromatogr Sci
|
2010
|
0.79
|
|
17
|
Determination of total cefozopran concentrations in human peritoneal fluid by HPLC with cefepime as an internal standard: Comparative pharmacokinetics in the fluid and plasma.
|
J Pharm Biomed Anal
|
2009
|
0.79
|
|
18
|
Gas chromatography-electron ionization-mass spectrometry quantitation of valproic acid and gabapentin, using dried plasma spots, for therapeutic drug monitoring in in-home medical care.
|
Biomed Chromatogr
|
2014
|
0.78
|
|
19
|
Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration.
|
Jpn J Antibiot
|
2008
|
0.78
|
|
20
|
Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.
|
Int J Antimicrob Agents
|
2010
|
0.78
|
|
21
|
Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.
|
Biol Pharm Bull
|
2014
|
0.78
|
|
22
|
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.
|
Dig Dis Sci
|
2007
|
0.77
|
|
23
|
Pharmacokinetics and pharmacodynamics of biapenem in human cerebrospinal fluid.
|
Int J Antimicrob Agents
|
2009
|
0.77
|
|
24
|
Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.
|
Int J Antimicrob Agents
|
2012
|
0.77
|
|
25
|
Development of initial loading procedure for teicoplanin in critically ill patients with severe infections.
|
Biol Pharm Bull
|
2013
|
0.77
|
|
26
|
[Arbekacin sulfate concentrations in peripheral lymph and in serum after intravenous injection: report of four cases].
|
Jpn J Antibiot
|
2012
|
0.76
|
|
27
|
[In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin].
|
Jpn J Antibiot
|
2014
|
0.76
|
|
28
|
Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
|
Pediatr Infect Dis J
|
2013
|
0.76
|
|
29
|
Reply to Soman et al and Frippiat et al.
|
Clin Infect Dis
|
2013
|
0.75
|
|
30
|
Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation.
|
J Chemother
|
2012
|
0.75
|
|
31
|
Factors affecting treatment and recurrence of Clostridium difficile infections.
|
Biol Pharm Bull
|
2014
|
0.75
|
|
32
|
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
|
J Antimicrob Chemother
|
2008
|
0.75
|
|
33
|
Pharmacokinetics of ampicillin-sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgery.
|
J Infect Chemother
|
2012
|
0.75
|
|
34
|
Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation.
|
Int J Antimicrob Agents
|
2013
|
0.75
|
|
35
|
Development and validation of a GC-EI-MS method with reduced adsorption loss for the quantification of olanzapine in human plasma.
|
Anal Bioanal Chem
|
2012
|
0.75
|
|
36
|
[Dosing regimen rationalization of biapenem in pediatric patients: use of Monte Carlo simulation].
|
Jpn J Antibiot
|
2009
|
0.75
|
|
37
|
Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen.
|
Int J Clin Pharmacol Ther
|
2015
|
0.75
|
|
38
|
Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment.
|
J Infect Chemother
|
2008
|
0.75
|
|
39
|
Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery.
|
J Chemother
|
2014
|
0.75
|
|
40
|
A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2006
|
0.75
|
|
41
|
Considerations of meropenem dosage for bacterial meningitis based on pharmacodynamics in cerebrospinal fluid.
|
Int J Antimicrob Agents
|
2008
|
0.75
|
|
42
|
Effects of domperidone on human plasma levels of motilin, somatostatin, gastrin, adrenocorticotropic hormone and cortisol.
|
Biol Pharm Bull
|
2005
|
0.75
|
|
43
|
Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
|
Biol Pharm Bull
|
2015
|
0.75
|
|
44
|
Population Pharmacokinetic Analysis and Pharmacodynamic Evaluation of Ampicillin-sulbactam in Pediatric Patients Using Plasma and Urine Data.
|
Pediatr Infect Dis J
|
2022
|
0.75
|